Univariate and multivariate survival analyses were performed to evaluate the impact of radiotherapy and clinicopathological factors (e.g., age, tumor size, histological grade, Ki67 index, and P53 status) on the prognosis of triple negative breast cancer patients with ≥ 4 positive lymph nodes. The gene discussed is TP53; the disease is triple-negative breast carcinoma.